Pharmaceutical Pipeline

[tm_spacer size=”xs:25;sm:30;md:50;lg:113″]
[tm_spacer size=”lg:60″]
[tm_heading custom_google_font=”” text_color=”custom” custom_text_color=”#24611d” animation=”fade-in” text=”Pharmaceutical Pipeline” font_size=”sm:24;md:30;lg:36″][tm_spacer size=”xs:4;sm:4;md:4;lg:8″][tm_heading tag=”h5″ custom_google_font=”” google_fonts=”font_family:Poppins%3A300%2Cregular%2C500%2C600%2C700|font_style:500%20medium%20regular%3A500%3Anormal” font_weight=”600″ text_color=”custom” custom_text_color=”#595959″ text=”Pharmaceutical Product Pipeline of Indication Specific Products” font_size=”lg:20″][tm_spacer size=”lg:27″][tm_heading tag=”div” custom_google_font=”” animation=”fade-in” text=”Pharmaceutical product pipeline following the traditional drug discovery
and development process for eventual submission to the applicable government
agencies, such as Health Canada or the FDA.*”]
[tm_spacer size=”xs:20;sm:20;md:20;lg:30″]

Primary focus on 6 therapeutic areas:

[tm_spacer size=”xs:10;sm:10;md:10;lg:25″][tm_image animation=”none” image=”5365″]

Current Pipeline in Various Stages of Pre-Clinical and Clinical Development

▪ Dermatology
▪ Pain
▪ Neurology

[tm_spacer size=”xs:10;sm:10;md:10;lg:25″]
Clinical Partners
  • SickKids Hospital
  • University Health Network
  • University of West Indies
  • Centro de Atencion e Investigacion Medica CAIMED S.A.S
Clinical Partners

▪ SickKids Hospital
▪ University Health Network

▪ University of West Indies
▪ Centro de Atencion e Investigacion Medica CAIMED S.A.S.

[tm_spacer size=”xs:10;sm:10;md:10;lg:25″]

[tm_spacer size=”xs:10;sm:10;md:10;lg:25″][tm_heading tag=”div” custom_google_font=”” animation=”fade-in” text=”*All projects are in Phase I or Phase II. Note that the regulatory process to bring these products to market is lengthy and complicated and Avicanna cannot currently comment as to when such products will come to market.” font_size=”xs:8;sm:8;md:8;lg:10″]
[tm_spacer size=”lg:60″]